Asarfi Hospital [ASARFI] vs Indraprastha Medical [INDRAMEDCO] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Asarfi Hospital Ltd. wins in 7 metrics, Indraprastha Medical Corporation Ltd. wins in 12 metrics, with 0 ties. Indraprastha Medical Corporation Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Asarfi Hospital Ltd. | Indraprastha Medical Corporation Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.14 | 20.08 | Indraprastha Medical Corporation Ltd. |
| Price-to-Book Ratio | 4.37 | 5.57 | Asarfi Hospital Ltd. |
| Debt-to-Equity Ratio | 58.07 | 4.76 | Indraprastha Medical Corporation Ltd. |
| PEG Ratio | 0.24 | -5.81 | Asarfi Hospital Ltd. |
| EV/EBITDA | 14.40 | 12.10 | Indraprastha Medical Corporation Ltd. |
| Profit Margin (TTM) | 10.17% | 12.60% | Indraprastha Medical Corporation Ltd. |
| Operating Margin (TTM) | 15.67% | 13.64% | Asarfi Hospital Ltd. |
| EBITDA Margin (TTM) | 15.67% | 13.64% | Asarfi Hospital Ltd. |
| Return on Equity | 19.09% | 26.98% | Indraprastha Medical Corporation Ltd. |
| Return on Assets (TTM) | 6.78% | 18.90% | Indraprastha Medical Corporation Ltd. |
| Free Cash Flow (TTM) | $-161.37M | $1.20B | Indraprastha Medical Corporation Ltd. |
| Dividend Yield | N/A | 0.95% | N/A |
| 1-Year Return | 45.21% | -13.77% | Asarfi Hospital Ltd. |
| Price-to-Sales Ratio (TTM) | 2.55 | 2.53 | Indraprastha Medical Corporation Ltd. |
| Enterprise Value | $4.47B | $32.43B | Indraprastha Medical Corporation Ltd. |
| EV/Revenue Ratio | 2.78 | 2.23 | Indraprastha Medical Corporation Ltd. |
| Gross Profit Margin (TTM) | 78.81% | 37.00% | Asarfi Hospital Ltd. |
| Revenue per Share (TTM) | $82 | $158 | Indraprastha Medical Corporation Ltd. |
| Earnings per Share (Diluted) | $8.29 | $19.94 | Indraprastha Medical Corporation Ltd. |
| Beta (Stock Volatility) | -0.92 | 0.58 | Asarfi Hospital Ltd. |
Asarfi Hospital Ltd. vs Indraprastha Medical Corporation Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Asarfi Hospital Ltd. | -2.67% | 8.48% | -1.90% | 32.35% | 7.54% | 14.49% |
| Indraprastha Medical Corporation Ltd. | 0.17% | 2.46% | -2.81% | 4.08% | -18.78% | -10.90% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Asarfi Hospital Ltd. | 45.21% | 84.29% | 84.29% | 84.29% | 84.29% | 84.29% |
| Indraprastha Medical Corporation Ltd. | -13.77% | 314.55% | 315.68% | 619.68% | 949.24% | 1,109.38% |
Performance & Financial Health Analysis: Asarfi Hospital Ltd. vs Indraprastha Medical Corporation Ltd.
| Metric | ASARFI | INDRAMEDCO |
|---|---|---|
| Market Information | ||
| Market Cap | ₹4.10B | ₹37.31B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 51,300 | 399,153 |
| 90 Day Avg. Volume | 54,500 | 289,583 |
| Last Close | ₹206.05 | ₹402.15 |
| 52 Week Range | ₹117.20 - ₹256.95 | ₹342.00 - ₹640.85 |
| % from 52W High | -19.81% | -37.25% |
| All-Time High | ₹256.95 (May 07, 2026) | ₹640.85 (Nov 06, 2025) |
| % from All-Time High | -19.81% | -37.25% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.40% | 0.14% |
| Quarterly Earnings Growth | 1.02% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.13% |
| Operating Margin (TTM) | 0.16% | 0.14% |
| Return on Equity (TTM) | 0.19% | 0.27% |
| Debt to Equity (MRQ) | 58.07 | 4.76 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹47.69 | ₹71.88 |
| Cash per Share (MRQ) | ₹8.73 | ₹50.31 |
| Operating Cash Flow (TTM) | ₹41.59M | ₹1.78B |
| Levered Free Cash Flow (TTM) | ₹-6,039,000 | ₹1.61B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.95% |
| Last 12-Month Dividend | N/A | ₹4.50 |
Valuation & Enterprise Metrics Analysis: Asarfi Hospital Ltd. vs Indraprastha Medical Corporation Ltd.
| Metric | ASARFI (Apr 26, 2026) | INDRAMEDCO (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.14 | 20.08 |
| Forward P/E | N/A | 18.63 |
| PEG Ratio | 0.24 | -5.81 |
| Price to Sales (TTM) | 2.55 | 2.53 |
| Price to Book (MRQ) | 4.37 | 5.57 |
| Market Capitalization | ||
| Market Capitalization | ₹4.10B | ₹37.31B |
| Enterprise Value | ₹4.47B | ₹32.43B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.78 | 2.23 |
| Enterprise to EBITDA | 14.40 | 12.10 |
| Risk & Other Metrics | ||
| Beta | -0.92 | 0.58 |
| Book Value per Share (MRQ) | ₹47.69 | ₹71.88 |
Financial Statements Comparison: Asarfi Hospital Ltd. vs Indraprastha Medical Corporation Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ASARFI (2025) | INDRAMEDCO (2025) |
|---|---|---|
| Revenue/Sales | 1.21B | 13.07B |
| Cost of Goods Sold | 299.00M | 8.53B |
| COGS % of Revenue | 24.8% | 65.3% |
| Gross Profit | 906.65M | 4.54B |
| Gross Margin | 75.2% | 34.7% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 124.34M | 2.10B |
| Operating Margin | 10.3% | 16.1% |
| EBITDA | 289.49M | 2.64B |
| EBITDA Margin | 24.0% | 20.2% |
| Pre-Tax Income | 143.11M | 2.16B |
| Pre-Tax Income % of Revenue | 11.9% | 16.6% |
| Income Tax | 37.35M | 553.30M |
| Income Tax % of Revenue | 3.1% | 4.2% |
| Net Income (Profit) | 105.76M | 1.61B |
| Profit Margin | 8.8% | 12.3% |
Balance Sheet & Liquidity Metrics
| Metric | ASARFI (2025) | INDRAMEDCO (2025) |
|---|---|---|
| Cash & Equivalents | 14.26M | 614.80M |
| Total Current Assets | 584.84M | 4.31B |
| Total Current Assets % of Revenue | 48.5% | 33.0% |
| Total Current Liabilities | 410.39M | 1.79B |
| Total Current Liabilities % of Revenue | 34.0% | 13.7% |
| Long-Term Debt | 338.29M | 305.40M |
| Long-Term Debt % of Revenue | 28.1% | 2.3% |
| Total Shareholders Equity | 809.83M | 5.97B |
| Retained Earnings | 353.69M | 4.75B |
| Retained Earnings % of Revenue | 29.3% | 36.4% |
| Property, Plant & Equipment | 168,000 | 2.60B |
Cash Flow Statement Comparison
| Metric | ASARFI (2025) | INDRAMEDCO (2025) |
|---|---|---|
| Operating Cash Flow | -76.47M | 1.78B |
| Operating Cash Flow % of Revenue | -6.3% | 13.6% |
| Capital Expenditures | -104.96M | -363.30M |
| Free Cash Flow | -161.37M | 1.20B |
| FCF Margin | -13.4% | 9.2% |
| Debt Repayment | -55.26M | N/A |
| Common Stock Repurchase | 0 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ASARFI | INDRAMEDCO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 19.68M | 91.67M |
| Float Shares | 5.70M | 41.01M |
| % Held by Insiders | 61.17% | 55.41% |
| % Held by Institutions | 0.00% | 0.57% |
| % Held by Public | 38.83% | 44.02% |
Dividend Analysis & Yield Comparison: Asarfi Hospital Ltd. vs Indraprastha Medical Corporation Ltd.
| Metric | ASARFI | INDRAMEDCO |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹4.50 |
| Last 12-Month Dividend Yield | N/A | 0.95% |
| 3-Year Avg Annual Dividend | N/A | ₹4.00 |
| 3-Year Avg Dividend Yield | N/A | 1.26% |
| 3-Year Total Dividends | N/A | ₹12.00 |
| Ex-Dividend Date | N/A | Sep 18, 2025 |